U.S. Markets open in 12 hrs, 50 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,226.94 | 203.52 | 2.03% |
| NASDAQ | 2,154.06 | 41.62 | 1.97% |
| S&P 500 | 1,093.08 | 23.78 | 2.22% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| EPS (TTM): | -0.318 | Current P/E Ratio: | — |
|---|---|---|---|
| Last Quarter's Earnings: | -0.05 | Current Quarter Estimate: | -0.065 |
| Last Fiscal Year Earnings: | -0.39 | Next Fiscal Year Estimate: | -0.275 |
| Analyst Consensus: | Buy | Dividend Rate: | — |
| Last Dividend: | — |
First Call Consensus Recommendation Buy
| Date | Previous Event | Listen | Transcript/Brief |
|---|---|---|---|
| 11/05/2009 | Q3 2009 ONCOLYTICS BIOTECH INC Earnings Release | — | — |
| 11/04/2009 | ONCOLYTICS BIOTECH INC at EBD Group Bio Europe Conference | — | — |
| 10/29/2009 | ONCOLYTICS BIOTECH INC at The 8th Annual BIO Investor Forum |  |
— |
| 10/02/2009 | Oncolytics Biotech(R) Inc. Announces Phase 3 Update Conference Call | — | Download($) |
| 09/10/2009 | ONCOLYTICS BIOTECH INC at Rodman & Renshaw Annual Global Investment Conference | — | — |
| 07/29/2009 | Q2 2009 ONCOLYTICS BIOTECH INC Earnings Release | — | — |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts